VEGFderived peptide

General Information


DRACP ID  DRACP04921

Peptide Name   VEGFderived peptide

Sequence  KSVRGKGKGQKRKRKKSRYK

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Exon 6a of VEGF gene

Type  Synthetic peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  VEGFR2

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C103H191N41O25

Absent amino acids  ACDEFHILMNPTW

Common amino acids  K

Mass  274296

Pl  12.56

Basic residues  12

Acidic residues  0

Hydrophobic residues  1

Net charge  12

Boman Index  -10970

Hydrophobicity  -263

Aliphatic Index  14.5

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  78.42

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21470139

Title  Anti-angiogenic peptides for cancer therapeutics

Doi 10.2174/138920111796117300

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.